Antigenic differences between normal and malignant cells of the cancer patient form the rationale for clinical immunotherapeutic strategies. While the central nervous system has traditionally been ...
Brain tumors or glioblastomas are one of the most difficult cancer types to treat. These masses are malignant tumors that are made up of abnormal neuronal | Immunology ...
and anti-tumor activity of ABM-1310 in patients(pts)with BRAF V600 mutated recurrent primary brain tumors:interim result ABM-1310治疗BRAF V600突变型复发性原发脑肿瘤患者的安全性、耐受性、药代动力学和抗肿瘤活性:I期研究的中期结果 CVM-005:Phase ...